The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
You are here Home Guidance and resources Sponsors Kadmon Oceania Pty Ltd Regulatory activities for this sponsor. Listen Print Share Loading... Type Prescription medicine decision summary (1) (-) Prescription medicine decision summary (1) Designation or determination (2) Designation or determination (2) Australian Public Assessment Report (AusPAR) (1) Australian Public Assessment Report (AusPAR) (1) Prescription medicine registration (1) Prescription medicine registration (1) Date 2021 (1) 2021 (1) Search Filters applied:Prescription medicine decision summaryClear all Sponsor content1 result(s) found, displaying 1 to 1 Rholistiq 26 November 2021 Prescription medicine decision summary TGA decision: Rholistiq (belumosudil mesilate) is approved to treat chronic graft-versus-host disease (GVHD)
Rholistiq 26 November 2021 Prescription medicine decision summary TGA decision: Rholistiq (belumosudil mesilate) is approved to treat chronic graft-versus-host disease (GVHD)